Feb. 29, 2012
SWCRF Launches Collaboration of Trusts and Foundations for a Cancer Cure
NEW YORK—On March 6, 2012, the Samuel Waxman Cancer Research Foundation will host a meeting at Baron Capital to launch its Collaboration of Trusts and Foundations for a Cancer Cure. Samuel Waxman, M.D., Distinguished Service Professor at Mount Sinai School of Medicine, Honorary Professor at Shanghai Jiao Tong University, will give a presentation entitled, “Curing Leukemia Through Philanthropy,” the true story of how an international collaboration of scientists in the U.S. and in China led to the cure of a form of leukemia known as acute promyelocytic leukemia (APL).
APL is a cancer of the blood and bone that once had a 100% mortality rate. With the advent of chemotherapy alone, the cure rate was approximately 25-30%. But a minimally toxic treatment using a Vitamin A derivative and a form of arsenic led to APL now having a 95% cure rate after five years.
The combination treatment reprograms cancer cells to behave like normal cells, which is the unique approach that the Samuel Waxman Cancer Research Foundation uses to tackle cancer at its root. The breakthrough is a result of a long-standing collaboration that began in the ‘80s between the Shanghai Institute of Hematology under the supervision of Zhu Chen, M.D., Ph.D., currently the Minister of Health in China, and the Mount Sinai laboratory of Samuel Waxman, M.D., the Founder and the Scientific Director of the Samuel Waxman Cancer Research Foundation.
“The Samuel Waxman Cancer Research Foundation played a role in the cure of APL by fostering an international collaboration between scientists. Collaboration is the key to bringing treatments to patients faster,” said Dr. Waxman. “By partnering with the SWCRF, donors can be certain that their investment is going toward funding innovative research that will make a lasting impact in people’s lives.”
About the Samuel Waxman Cancer Research Foundation
The Samuel Waxman Cancer Research Foundation is an international organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research, focusing on uncovering the causes of cancer and reprogramming cancer cells.
We dedicate ourselves to delivering tailored, minimally toxic treatments to patients. Our mission is to eradicate cancer by bridging the gap between lab science and the patient.
Through our collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the SWCRF has awarded more than $75 million to support the work of nearly 200 researchers across the globe.
For more information, visit waxmancancer.org.